Answer
The most frequently reported side effects of palopegteriparatide in clinical trials were injection site reactions (21.6%), headache (18.7%) and paraesthesia (13.7%).
Sources for this answer
- Yorvipath 294 micrograms/0.98 mL solution for injection in pre filled penAscendis Pharma UK Limited · emc · SmPC §4.8 Undesirable effects · Version 4Document updated
Sources checked